All products processed by CellRight Technologies® are processed using CellRight's proprietary BioRinse™ sterilisation technology, and in accordance with AATB Standards and FDA federal regulations. BioRinse™ is CellRight Technologies® validated steriliszation process that uses proprietary rinsing agents in multiple combinations designed to kill pathogenic microorganisms, vegetative bacteria and spores. These steps include the removal of debris, blood, bone marrow and lipids, components associated with disease transmission. The BioRinse™ process is a technologically advanced science developed by CellRight Technologies® for use in product families including CellRight Technologies® verified* osteoinductive Matrix OI®, MatrixCellect® 100 DBM putty, MatrixCellect® 100 DBM Crunch, ConCelltrate® 100; and its sports medicine, dental, and conventional products. BioRinse™ in combination with our final low dose sterilisation step under low-temperatures ensures a medical device sterility assurance level (SAL) of 10 -6 in accordance with a Sterile "R" claim.
*Each lot, post-sterilisation is verified for osteoinductivity.